Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8
Open Access
- 1 May 2015
- journal article
- immunology
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (21) , 13017-13027
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30 CA008748-48)
This publication has 37 references indexed in Scilit:
- Cross-platform comparison of glycan microarray formatsGlycobiology, 2014
- Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapyFEBS Letters, 2013
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First RemissionJournal of Clinical Oncology, 2012
- Yeast Display of Engineered Antibody Domains2012
- Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapyClinical and Experimental Immunology, 2012
- Beyond natural antibodies: the power of in vitro display technologiesNature Biotechnology, 2011
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II StudyJournal of Clinical Oncology, 2010
- Glycomimetic drugs--a new source of therapeutic opportunities.2009
- Reducing Epitope Spread during Affinity Maturation of an Anti-Ganglioside GD2 AntibodyThe Journal of Immunology, 2009
- Gangliosides as Therapeutic Targets for CancerBioDrugs, 2003